Olema Pharmaceuticals, Inc. (OLMA) Insider Trading

Over the last 6 months, 140 institutions increased and 94 reduced their position (13F).

Insider Activity

Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Dec
Jan
Sep
Dec
Jan
Mar
Context3-month price -16.1%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 23, 2026Horning SandradirectorGrant29,500$9.51
Jun 23, 2026Larson YidirectorGrant29,500$9.51
Jun 23, 2026Raman PrakashdirectorGrant29,500$9.51
Jun 23, 2026RAPPAPORT ANDREWdirectorGrant29,500$9.51
Jun 23, 2026Graham G. WalmsleydirectorGrant29,500$9.51
Jun 23, 2026BVF PARTNERS L P/ILdirector, other: See Explanation of ResponsesGrant29,500$9.51
Jun 23, 2026Harmon CyrusdirectorGrant29,500$9.51
Jun 23, 2026BUTITTA CYNTHIA MdirectorGrant29,500$9.51
Jun 23, 2026Garland J. ScottdirectorGrant29,500$9.51
Jun 23, 2026Hrustanovic GorjandirectorGrant29,500$9.51
Jun 23, 2026CLARK IAN TdirectorGrant29,500$9.51
Apr 29, 2026Raman PrakashdirectorGrant2,911$14.59
Apr 29, 2026Raman PrakashdirectorGrant24,150$14.59
Mar 5, 2026Mitchell Shawnteofficer: CHIEF LEGAL OFFICERSell24,767$24.25
Mar 5, 2026Mitchell Shawnteofficer: CHIEF LEGAL OFFICEROption25,000$4.37
Mar 5, 2026Mitchell Shawnteofficer: CHIEF LEGAL OFFICEROption15,000$4.37
Mar 5, 2026Mitchell Shawnteofficer: CHIEF LEGAL OFFICERSell15,000$23.01
Mar 5, 2026Mitchell Shawnteofficer: CHIEF LEGAL OFFICERSell233$24.69
Feb 17, 2026Austin Sasha Luofficer: VP of Finance and ControllerGrant11,700—
Feb 17, 2026Austin Sasha Luofficer: VP of Finance and ControllerGrant29,250$25.65
Feb 4, 2026Zojwalla Naseemofficer: CHIEF MEDICAL OFFICERGrant250,000$25.65
Feb 4, 2026Myles David C.officer: CH. DISCOV. & NON-CLIN DEV OFFGrant250,000$25.65
Feb 4, 2026Zojwalla Naseemofficer: CHIEF MEDICAL OFFICERGrant106,250$25.65
Feb 4, 2026Bohen Seandirector, officer: PRESIDENT AND CEOGrant275,000$25.65
Feb 4, 2026Bohen Seandirector, officer: PRESIDENT AND CEOGrant850,000$25.65
Feb 4, 2026Mitchell Shawnteofficer: CHIEF LEGAL OFFICERGrant56,250$25.65
Feb 4, 2026Mitchell Shawnteofficer: CHIEF LEGAL OFFICERGrant220,000$25.65
Feb 4, 2026Myles David C.officer: CH. DISCOV. & NON-CLIN DEV OFFGrant106,250$25.65
Jan 21, 2026Harmon CyrusdirectorSell10,000$26.88
Jan 16, 2026Harmon CyrusdirectorSell3,489$29.12

Source: OLMA SEC Form 4 filings, latest Jun 23, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their OLMA positions over the last 6 months (SEC Form 13F).

Increased
140
New positions
133
Reduced
94
Sold out
65
Largest moves
InstitutionActionSharesFiled
JANUS HENDERSON GROUP PLCIncreased14.2MMay 18, 2026
FMR LLCIncreased10.4MMay 15, 2026
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLCIncreased8.5MFeb 17, 2026
PARADIGM BIOCAPITAL ADVISORS LPIncreased8.0MMay 15, 2026
PARADIGM BIOCAPITAL ADVISORS LPIncreased7.5MFeb 17, 2026
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLCReduced7.5MMay 15, 2026
JANUS HENDERSON GROUP PLCIncreased6.7MFeb 17, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position6.2MMay 15, 2026
BLACKROCK, INC.Increased5.7MMay 13, 2026
BLACKROCK, INC.Increased5.6MFeb 12, 2026
BVF INC/ILUnchanged5.3MMay 15, 2026
BVF INC/ILUnchanged5.3MFeb 17, 2026
FMR LLCIncreased5.0MFeb 17, 2026
SIREN, L.L.C.Increased4.8MMay 14, 2026
CORMORANT ASSET MANAGEMENT, LPIncreased4.4MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.

← Back to OLMA overview (price, financials, earnings)